Native gp41 assay

Details for Australian Patent Application No. 2008278970 (hide)

Owner Tibotec Pharmaceuticals

Inventors Bunkens, Lieve Elisabeth Louis; Ohagen, Asa Catrine; Van Acker, Koenraad Lodewijk August; Dams, Gery Karel Julia; Meersseman, Geert Henri; Holemans, Pascale Alice Jan

Agent Shelston IP

Pub. Number AU-A-2008278970

PCT Pub. Number WO2009/013352

Priority 07113185.8 26.07.07 EP

Filing date 25 July 2008

Wipo publication date 29 January 2009

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

21 January 2010 PCT application entered the National Phase

  PCT publication WO2009/013352 Priority application(s): WO2009/013352

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008278974-Anti-HIV tablet formulations comprising darunavir

2008278969-Macrolide solid-state forms